A citation-based method for searching scientific literature

Andrea E de Jong, Yvonne M C Hendriks, Jan H Kleibeuker, Sybrand Y de Boer, Annemieke Cats, Gerrit Griffioen, Fokko M Nagengast, Frits G Nelis, Matti A Rookus, Hans F A Vasen. Gastroenterology 2006
Times Cited: 179







List of co-cited articles
796 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltomäki, A De La Chapelle, J P Mecklin. Gastroenterology 2000
920
64

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Asad Umar, C Richard Boland, Jonathan P Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M Lindor, Lawrence J Burgart, Richard Hamelin,[...]. J Natl Cancer Inst 2004
38

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.
Hans F A Vasen, Ignacio Blanco, Katja Aktan-Collan, Jessica P Gopie, Angel Alonso, Stefan Aretz, Inge Bernstein, Lucio Bertario, John Burn, Gabriel Capella,[...]. Gut 2013
416
38


Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Kathleen M Schmeler, Henry T Lynch, Lee-may Chen, Mark F Munsell, Pamela T Soliman, Mary Beth Clark, Molly S Daniels, Kristin G White, Stephanie G Boyd-Rogers, Peggy G Conrad,[...]. N Engl J Med 2006
465
31

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Hidewaki Nakagawa, Kaisa Sotamaa, Thomas W Prior, Judith Westman,[...]. N Engl J Med 2005
905
30

One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
Hans F A Vasen, Mohamed Abdirahman, Richard Brohet, Alexandra M J Langers, Jan H Kleibeuker, Mariette van Kouwen, Jan Jacob Koornstra, Henk Boot, Annemieke Cats, Evelien Dekker,[...]. Gastroenterology 2010
160
27

Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Mark Clendenning, Kaisa Sotamaa, Thomas Prior, Judith A Westman,[...]. J Clin Oncol 2008
532
24

Hereditary colorectal cancer.
Henry T Lynch, Albert de la Chapelle. N Engl J Med 2003
24

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Valérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, Sophie Grandjouan, Laetitia Huiart, Michel Longy, Rosine Guimbaud, Bruno Buecher, Yves-Jean Bignon, Olivier Caron,[...]. JAMA 2011
577
24

Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.
Noralane M Lindor, Gloria M Petersen, Donald W Hadley, Anita Y Kinney, Susan Miesfeldt, Karen H Lu, Patrick Lynch, Wylie Burke, Nancy Press. JAMA 2006
418
20

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
John Burn, Anne-Marie Gerdes, Finlay Macrae, Jukka-Pekka Mecklin, Gabriela Moeslein, Sylviane Olschwang, Diane Eccles, D Gareth Evans, Eamonn R Maher, Lucio Bertario,[...]. Lancet 2011
583
18

Identification of Lynch syndrome among patients with colorectal cancer.
Leticia Moreira, Francesc Balaguer, Noralane Lindor, Albert de la Chapelle, Heather Hampel, Lauri A Aaltonen, John L Hopper, Loic Le Marchand, Steven Gallinger, Polly A Newcomb,[...]. JAMA 2012
293
17

Cancer risk in mutation carriers of DNA-mismatch-repair genes.
M Aarnio, R Sankila, E Pukkala, R Salovaara, L A Aaltonen, A de la Chapelle, P Peltomäki, J P Mecklin, H J Järvinen. Int J Cancer 1999
805
16


The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
Leigha Senter, Mark Clendenning, Kaisa Sotamaa, Heather Hampel, Jane Green, John D Potter, Annika Lindblom, Kristina Lagerstedt, Stephen N Thibodeau, Noralane M Lindor,[...]. Gastroenterology 2008
342
16

Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Heather Hampel, Wendy Frankel, Jenny Panescu, Janet Lockman, Kaisa Sotamaa, Daniel Fix, Ilene Comeras, Jennifer La Jeunesse, Hidewaki Nakagawa, Judith A Westman,[...]. Cancer Res 2006
382
16

Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.
Susan Parry, Aung Ko Win, Bryan Parry, Finlay A Macrae, Lyle C Gurrin, James M Church, John A Baron, Graham G Giles, Barbara A Leggett, Ingrid Winship,[...]. Gut 2011
154
16


Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.
Uri Ladabaum, Grace Wang, Jonathan Terdiman, Amie Blanco, Miriam Kuppermann, C Richard Boland, James Ford, Elena Elkin, Kathryn A Phillips. Ann Intern Med 2011
234
15

Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.
Rebecca A Barnetson, Albert Tenesa, Susan M Farrington, Iain D Nicholl, Roseanne Cetnarskyj, Mary E Porteous, Harry Campbell, Malcolm G Dunlop. N Engl J Med 2006
309
14

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).
H F Vasen, J P Mecklin, P M Khan, H T Lynch. Dis Colon Rectum 1991
14

Risks of Lynch syndrome cancers for MSH6 mutation carriers.
Laura Baglietto, Noralane M Lindor, James G Dowty, Darren M White, Anja Wagner, Encarna B Gomez Garcia, Annette H J T Vriends, Nicola R Cartwright, Rebecca A Barnetson, Susan M Farrington,[...]. J Natl Cancer Inst 2010
229
14

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.
Glenn E Palomaki, Monica R McClain, Stephanie Melillo, Heather L Hampel, Stephen N Thibodeau. Genet Med 2009
319
14

Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
Heikki J Järvinen, Laura Renkonen-Sinisalo, Katja Aktán-Collán, Päivi Peltomäki, Lauri A Aaltonen, Jukka-Pekka Mecklin. J Clin Oncol 2009
176
14

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.
H T Lynch, P M Lynch, S J Lanspa, C L Snyder, J F Lynch, C R Boland. Clin Genet 2009
485
14

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
Pål Møller, Toni Seppälä, Inge Bernstein, Elke Holinski-Feder, Paola Sala, D Gareth Evans, Annika Lindblom, Finlay Macrae, Ignacio Blanco, Rolf Sijmons,[...]. Gut 2017
231
14

A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines.
M A Rodriguez-Bigas, C R Boland, S R Hamilton, D E Henson, J R Jass, P M Khan, H Lynch, M Perucho, T Smyrk, L Sobin,[...]. J Natl Cancer Inst 1997
784
13

The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.
Patrice Watson, Hans F A Vasen, Jukka-Pekka Mecklin, Inge Bernstein, Markku Aarnio, Heikki J Järvinen, Torben Myrhøj, Lone Sunde, Juul T Wijnen, Henry T Lynch. Int J Cancer 2008
365
13

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.
Marjolijn J L Ligtenberg, Roland P Kuiper, Tsun Leung Chan, Monique Goossens, Konnie M Hebeda, Marsha Voorendt, Tracy Y H Lee, Danielle Bodmer, Eveline Hoenselaar, Sandra J B Hendriks-Cornelissen,[...]. Nat Genet 2009
469
12

Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
L A Aaltonen, R Salovaara, P Kristo, F Canzian, A Hemminki, P Peltomäki, R B Chadwick, H Kääriäinen, M Eskelinen, H Järvinen,[...]. N Engl J Med 1998
881
12

Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome.
Laura Renkonen-Sinisalo, Ralf Bützow, Arto Leminen, Pentti Lehtovirta, Jukka-Pekka Mecklin, Heikki J Järvinen. Int J Cancer 2007
126
12

Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.
Elena Stoffel, Bhramar Mukherjee, Victoria M Raymond, Nabihah Tayob, Fay Kastrinos, Jennifer Sparr, Fei Wang, Prathap Bandipalliam, Sapna Syngal, Stephen B Gruber. Gastroenterology 2009
232
12


Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer.
Christoph Engel, Nils Rahner, Karsten Schulmann, Elke Holinski-Feder, Timm O Goecke, Hans K Schackert, Matthias Kloor, Verena Steinke, Holger Vogelsang, Gabriela Möslein,[...]. Clin Gastroenterol Hepatol 2010
103
12

Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
Catherine Julié, Christophe Trésallet, Antoine Brouquet, Céline Vallot, Ute Zimmermann, Emmanuel Mitry, François Radvanyi, Etienne Rouleau, Rosette Lidereau, Florence Coulet,[...]. Am J Gastroenterol 2008
91
12

Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.
Heather Hampel, Julie A Stephens, Eero Pukkala, Risto Sankila, Lauri A Aaltonen, Jukka-Pekka Mecklin, Albert de la Chapelle. Gastroenterology 2005
283
11

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).
H F A Vasen, G Möslein, A Alonso, I Bernstein, L Bertario, I Blanco, J Burn, G Capella, C Engel, I Frayling,[...]. J Med Genet 2007
357
11

Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.
Aung Ko Win, Joanne P Young, Noralane M Lindor, Katherine M Tucker, Dennis J Ahnen, Graeme P Young, Daniel D Buchanan, Mark Clendenning, Graham G Giles, Ingrid Winship,[...]. J Clin Oncol 2012
206
11

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database.
Pål Møller, Toni T Seppälä, Inge Bernstein, Elke Holinski-Feder, Paulo Sala, D Gareth Evans, Annika Lindblom, Finlay Macrae, Ignacio Blanco, Rolf H Sijmons,[...]. Gut 2018
196
11

Recommendations to improve identification of hereditary and familial colorectal cancer in Europe.
H F A Vasen, G Möslein, A Alonso, S Aretz, I Bernstein, L Bertario, I Blanco, S Bulow, J Burn, G Capella,[...]. Fam Cancer 2010
81
12

Prediction of germline mutations and cancer risk in the Lynch syndrome.
Sining Chen, Wenyi Wang, Shing Lee, Khedoudja Nafa, Johanna Lee, Kathy Romans, Patrice Watson, Stephen B Gruber, David Euhus, Kenneth W Kinzler,[...]. JAMA 2006
243
10

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
C R Boland, S N Thibodeau, S R Hamilton, D Sidransky, J R Eshleman, R W Burt, S J Meltzer, M A Rodriguez-Bigas, R Fodde, G N Ranzani,[...]. Cancer Res 1998
10

Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
Karen H Lu, Mai Dinh, Wendy Kohlmann, Patrice Watson, Jane Green, Sapna Syngal, Prathap Bandipalliam, Lee-May Chen, Brian Allen, Peggy Conrad,[...]. Obstet Gynecol 2005
224
10

Cancer risk associated with germline DNA mismatch repair gene mutations.
M G Dunlop, S M Farrington, A D Carothers, A H Wyllie, L Sharp, J Burn, B Liu, K W Kinzler, B Vogelstein. Hum Mol Genet 1997
493
10

Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families.
Wouter H de Vos tot Nederveen Cappel, Fokko M Nagengast, Gerrit Griffioen, Fred H Menko, Babs G Taal, Jan H Kleibeuker, Hans F Vasen. Dis Colon Rectum 2002
148
10

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.
E Barrow, L Robinson, W Alduaij, A Shenton, T Clancy, F Lalloo, J Hill, D G Evans. Clin Genet 2009
193
10

Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years.
Celine H M Leenen, Margot G F van Lier, Helena C van Doorn, Monique E van Leerdam, Sjarlot G Kooi, Judith de Waard, Robert F Hoedemaeker, Ans M W van den Ouweland, Sanne M Hulspas, Hendrikus J Dubbink,[...]. Gynecol Oncol 2012
90
11

Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
Lucía Pérez-Carbonell, Clara Ruiz-Ponte, Carla Guarinos, Cristina Alenda, Artemio Payá, Alejandro Brea, Cecilia M Egoavil, Adela Castillejo, Victor M Barberá, Xavier Bessa,[...]. Gut 2012
132
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.